{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:47:22Z","timestamp":1740138442735,"version":"3.37.3"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T00:00:00Z","timestamp":1692144000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T00:00:00Z","timestamp":1692144000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Youth Foundation of He\u2019nan Scientific Committee","award":["202300410416"],"award-info":[{"award-number":["202300410416"]}]},{"name":"Henan province medical science, technology breakthrough plan project","award":["LHGJ20190033"],"award-info":[{"award-number":["LHGJ20190033"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biotechnol"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s12033-023-00850-8","type":"journal-article","created":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T10:02:36Z","timestamp":1692180156000},"page":"2087-2094","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comprehensive Analysis of Expression and Pathway for CD27 in Esophageal Cancer"],"prefix":"10.1007","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6759-8252","authenticated-orcid":false,"given":"Fan-kai","family":"Xiao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,8,16]]},"reference":[{"issue":"6","key":"850_CR1","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1007\/s12328-020-01237-x","volume":"13","author":"DJ Uhlenhopp","year":"2020","unstructured":"Uhlenhopp, D. J., Then, E. O., Sunkara, T., & Gaduputi, V. (2020). Epidemiology of esophageal cancer: Update in global trends, etiology and risk factors. Clinical Journal of Gastroenterology, 13(6), 1010\u20131021.","journal-title":"Clinical Journal of Gastroenterology"},{"issue":"1","key":"850_CR2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s00595-019-01878-7","volume":"50","author":"M Watanabe","year":"2020","unstructured":"Watanabe, M., Otake, R., Kozuki, R., et al. (2020). Recent progress in multidisciplinary treatment for patients with esophageal cancer. Surgery Today, 50(1), 12\u201320.","journal-title":"Surgery Today"},{"issue":"1","key":"850_CR3","first-page":"22","volume":"95","author":"MW Short","year":"2017","unstructured":"Short, M. W., Burgers, K. G., & Fry, V. T. (2017). Esophageal Cancer. American family physician., 95(1), 22\u201328.","journal-title":"American family physician."},{"issue":"4","key":"850_CR4","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1053\/j.seminoncol.2015.05.014","volume":"42","author":"MF Sanmamed","year":"2015","unstructured":"Sanmamed, M. F., Pastor, F., Rodriguez, A., et al. (2015). Agonists of Co-stimulation in Cancer Immunotherapy Directed Against CD137, OX40, GITR, CD27, CD28, and ICOS. Seminars in Oncology, 42(4), 640\u2013655.","journal-title":"Seminars in Oncology"},{"issue":"8","key":"850_CR5","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1517\/14728222.2016.1158812","volume":"20","author":"H Wajant","year":"2016","unstructured":"Wajant, H. (2016). Therapeutic targeting of CD70 and CD27. Expert Opinion on Therapeutic Targets, 20(8), 959\u2013973.","journal-title":"Expert Opinion on Therapeutic Targets"},{"issue":"1","key":"850_CR6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/cyto.b.21249","volume":"90","author":"M Stetler-Stevenson","year":"2016","unstructured":"Stetler-Stevenson, M., Paiva, B., Stoolman, L., et al. (2016). Consensus guidelines for myeloma minimal residual disease sample staining and data acquisition. Cytometry. Part B, Clinical Cytometry, 90(1), 26\u201330.","journal-title":"Cytometry. Part B, Clinical Cytometry"},{"issue":"9","key":"850_CR7","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1038\/s41591-020-0910-8","volume":"26","author":"C Riether","year":"2020","unstructured":"Riether, C., Pabst, T., Hopner, S., et al. (2020). Targeting CD70 with cusatuzumab eliminates acute myeloid leukemia stem cells in patients treated with hypomethylating agents. Nature Medicine, 26(9), 1459\u20131467.","journal-title":"Nature Medicine"},{"key":"850_CR8","doi-asserted-by":"crossref","unstructured":"Tanaka Y, Takeda R, Fukushima T, et al. Eliminating chronic myeloid leukemia stem cells by IRAK1\/4 inhibitors. Nat Commun. Jan 12 2022;13(1):271.","DOI":"10.1038\/s41467-021-27928-8"},{"issue":"7","key":"850_CR9","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1093\/rheumatology\/kex067","volume":"56","author":"V Reddy","year":"2017","unstructured":"Reddy, V., Klein, C., Isenberg, D. A., et al. (2017). Obinutuzumab induces superior B-cell cytotoxicity to rituximab in rheumatoid arthritis and systemic lupus erythematosus patient samples. Rheumatology (Oxford), 56(7), 1227\u20131237.","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"850_CR10","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1182\/blood-2007-03-082578","volume":"110","author":"ZZ Yang","year":"2007","unstructured":"Yang, Z. Z., Novak, A. J., Ziesmer, S. C., Witzig, T. E., & Ansell, S. M. (2007). CD70+ non-Hodgkin lymphoma B cells induce Foxp3 expression and regulatory function in intratumoral CD4+CD25 T cells. Blood, 110(7), 2537\u20132544.","journal-title":"Blood"},{"issue":"3","key":"850_CR11","doi-asserted-by":"publisher","first-page":"203","DOI":"10.2217\/imt-2019-0153","volume":"12","author":"D Schizas","year":"2020","unstructured":"Schizas, D., Charalampakis, N., Kole, C., et al. (2020). Immunotherapy for esophageal cancer: A 2019 update. Immunotherapy, 12(3), 203\u2013218.","journal-title":"Immunotherapy"},{"issue":"1","key":"850_CR12","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1182\/blood-2017-07-741025","volume":"131","author":"SL Buchan","year":"2018","unstructured":"Buchan, S. L., Rogel, A., & Al-Shamkhani, A. (2018). The immunobiology of CD27 and OX40 and their potential as targets for cancer immunotherapy. Blood, 131(1), 39\u201348.","journal-title":"Blood"},{"issue":"Suppl 3","key":"850_CR13","volume":"4","author":"AM Starzer","year":"2020","unstructured":"Starzer, A. M., & Berghoff, A. S. (2020). New emerging targets in cancer immunotherapy: CD27 (TNFRSF7). ESMO Open., 4(Suppl 3), e000629.","journal-title":"ESMO Open."},{"issue":"34","key":"850_CR14","doi-asserted-by":"publisher","first-page":"3923","DOI":"10.1038\/onc.2012.567","volume":"32","author":"EM Beauchamp","year":"2013","unstructured":"Beauchamp, E. M., & Platanias, L. C. (2013). The evolution of the TOR pathway and its role in cancer. Oncogene, 32(34), 3923\u20133932.","journal-title":"Oncogene"},{"key":"850_CR15","doi-asserted-by":"crossref","unstructured":"Paquette M, El-Houjeiri L, Pause A. mTOR Pathways in Cancer and Autophagy. Cancers (Basel). 2018;10(1).","DOI":"10.3390\/cancers10010018"},{"issue":"2","key":"850_CR16","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/jcmm.12408","volume":"19","author":"K Kami\u0144ska","year":"2015","unstructured":"Kami\u0144ska, K., Szczylik, C., Bielecka, Z. F., et al. (2015). The role of the cell-cell interactions in cancer progression. Journal of cellular and molecular medicine., 19(2), 283\u2013296.","journal-title":"Journal of cellular and molecular medicine."},{"key":"850_CR17","doi-asserted-by":"crossref","unstructured":"Yousefi SR, Alshamsi HA, Amiri O, Salavati-Niasari M. Synthesis, characterization and application of Co\/Co3O4 nanocomposites as an effective photocatalyst for discoloration of organic dye contaminants in wastewater and antibacterial properties. J Mol Liq 2021;337.","DOI":"10.1016\/j.molliq.2021.116405"},{"issue":"4","key":"850_CR18","doi-asserted-by":"publisher","first-page":"e833","DOI":"10.1097\/MPH.0000000000002453","volume":"44","author":"D Kose","year":"2022","unstructured":"Kose, D., Guzelcicek, A., Oz, O., et al. (2022). The mutation of CD27 deficiency presented with familial hodgkin lymphoma and a review of the literature. Journal of Pediatric Hematology\/Oncology, 44(4), e833\u2013e843.","journal-title":"Journal of Pediatric Hematology\/Oncology"},{"issue":"3","key":"850_CR19","doi-asserted-by":"publisher","first-page":"639","DOI":"10.4049\/jimmunol.1900288","volume":"203","author":"KA Remedios","year":"2019","unstructured":"Remedios, K. A., Meyer, L., Zirak, B., et al. (2019). CD27 Promotes CD4(+) Effector T Cell Survival in Response to Tissue Self-Antigen. The Journal of Immunology, 203(3), 639\u2013646.","journal-title":"The Journal of Immunology"},{"issue":"1","key":"850_CR20","doi-asserted-by":"publisher","first-page":"4089","DOI":"10.1038\/s41467-020-17898-8","volume":"11","author":"P Gantner","year":"2020","unstructured":"Gantner, P., Pagliuzza, A., Pardons, M., et al. (2020). Single-cell TCR sequencing reveals phenotypically diverse clonally expanded cells harboring inducible HIV proviruses during ART. Nat Commun, 11(1), 4089.","journal-title":"Nat Commun"},{"issue":"1","key":"850_CR21","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13046-021-02215-y","volume":"41","author":"T Flieswasser","year":"2022","unstructured":"Flieswasser, T., Van den Eynde, A., Van Audenaerde, J., et al. (2022). The CD70-CD27 axis in oncology: The new kids on the block. J Exp Clin Cancer Res., 41(1), 12.","journal-title":"J Exp Clin Cancer Res."},{"issue":"8","key":"850_CR22","doi-asserted-by":"publisher","first-page":"4174","DOI":"10.4049\/jimmunol.1300409","volume":"191","author":"LZ He","year":"2013","unstructured":"He, L. Z., Prostak, N., Thomas, L. J., et al. (2013). Agonist anti-human CD27 monoclonal antibody induces T cell activation and tumor immunity in human CD27-transgenic mice. The Journal of Immunology, 191(8), 4174\u20134183.","journal-title":"The Journal of Immunology"},{"issue":"10","key":"850_CR23","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1158\/1078-0432.CCR-17-3057","volume":"24","author":"SL Buchan","year":"2018","unstructured":"Buchan, S. L., Fallatah, M., Thirdborough, S. M., et al. (2018). PD-1 Blockade and CD27 Stimulation Activate Distinct Transcriptional Programs That Synergize for CD8(+) T-Cell-Driven Antitumor Immunity. Clinical Cancer Research, 24(10), 2383\u20132394.","journal-title":"Clinical Cancer Research"},{"issue":"12","key":"850_CR24","doi-asserted-by":"publisher","first-page":"3451","DOI":"10.1007\/s00262-021-02936-1","volume":"70","author":"AJR McGray","year":"2021","unstructured":"McGray, A. J. R., Eppolito, C., Miliotto, A., et al. (2021). A prime\/boost vaccine platform efficiently identifies CD27 agonism and depletion of myeloid-derived suppressor cells as therapies that rationally combine with checkpoint blockade in ovarian cancer. Cancer Immunology, Immunotherapy, 70(12), 3451\u20133460.","journal-title":"Cancer Immunology, Immunotherapy"},{"issue":"2","key":"850_CR25","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1046\/j.1365-2141.2003.04069.x","volume":"120","author":"Y Katayama","year":"2003","unstructured":"Katayama, Y., Sakai, A., Oue, N., et al. (2003). A possible role for the loss of CD27-CD70 interaction in myelomagenesis. British journal of haematology., 120(2), 223\u2013234.","journal-title":"British journal of haematology."},{"key":"850_CR26","doi-asserted-by":"crossref","unstructured":"Kong F, Ye Q, Xiong Y. Comprehensive analysis of prognosis and immune function of CD70-CD27 signaling axis in pan-cancer. Functional & integrative genomics. Jan 26 2023;23(1):48.","DOI":"10.1007\/s10142-023-00977-6"},{"issue":"12","key":"850_CR27","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1016\/j.exphem.2005.10.005","volume":"33","author":"A Nilsson","year":"2005","unstructured":"Nilsson, A., de Milito, A., Mowafi, F., et al. (2005). Expression of CD27-CD70 on early B cell progenitors in the bone marrow: Implication for diagnosis and therapy of childhood ALL. Experimental Hematology, 33(12), 1500\u20131507.","journal-title":"Experimental Hematology"},{"issue":"2","key":"850_CR28","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1084\/jem.20152008","volume":"214","author":"C Riether","year":"2017","unstructured":"Riether, C., Schurch, C. M., Buhrer, E. D., et al. (2017). CD70\/CD27 signaling promotes blast stemness and is a viable therapeutic target in acute myeloid leukemia. Journal of Experimental Medicine, 214(2), 359\u2013380.","journal-title":"Journal of Experimental Medicine"},{"issue":"2","key":"850_CR29","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1172\/JCI45977","volume":"122","author":"C Schurch","year":"2012","unstructured":"Schurch, C., Riether, C., Matter, M. S., Tzankov, A., & Ochsenbein, A. F. (2012). CD27 signaling on chronic myelogenous leukemia stem cells activates Wnt target genes and promotes disease progression. The Journal of Clinical Investigation, 122(2), 624\u2013638.","journal-title":"The Journal of Clinical Investigation"}],"container-title":["Molecular Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-023-00850-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12033-023-00850-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-023-00850-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T21:11:07Z","timestamp":1722028267000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12033-023-00850-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,16]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["850"],"URL":"https:\/\/doi.org\/10.1007\/s12033-023-00850-8","relation":{},"ISSN":["1073-6085","1559-0305"],"issn-type":[{"type":"print","value":"1073-6085"},{"type":"electronic","value":"1559-0305"}],"subject":[],"published":{"date-parts":[[2023,8,16]]},"assertion":[{"value":"25 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human and animal participants"}}]}}